Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000261070 | SCV000341312 | uncertain significance | not provided | 2016-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079088 | SCV000658074 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2024-05-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001334567 | SCV001527447 | uncertain significance | Autosomal dominant nocturnal frontal lobe epilepsy 1 | 2018-02-01 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000261070 | SCV001993138 | uncertain significance | not provided | 2019-03-13 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002519288 | SCV003689025 | likely benign | Inborn genetic diseases | 2022-07-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |